For patient-related information about the ICT-107 cancer vaccine phase II program please:

  1. Access the ICT-107 FAQ (Frequently Asked Questions) click here.
  2. Send an email message to clintrials@imuc.com, including your contact information and your specific questions.
  3. Call 818 264 2315 and leave a brief message, including your contact information and questions.

Someone knowledgeable about the ICT-107 clinical program will respond to your inquiry shortly.

PRESS RELEASES

Wednesday, January 28, 2015
ImmunoCellular Therapeutics to Present at the BIO CEO & Investor Conference on February 9, 2015 read more ...
Wednesday, December 17, 2014
ImmunoCellular Therapeutics Announces Issuance of Key Patent For ICT-107 Cancer Vaccine read more ...
Monday, December 01, 2014
ImmunoCellular Therapeutics Receives Positive Regulatory Feedback from European Medicines Agency on read more ...

EVENTS

Wednesday, January 28, 2015
ImmunoCellular Therapeutics February 9, 2015 BIO CEO presentation webcast
Friday, November 14, 2014
ImmunoCellular to Host Conference Call on Tuesday, November 18th
Friday, September 26, 2014
ImmunoCellular Therapeutics October 1, 2014 Livingston Securities presentation webcast
 
Copyright 2015 by Immunocellular Therapeutics, Ltd.
All Rights Reserved